دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Issue Highlights page
doi : 10.1016/S0360-3016(23)07598-3
Volume 117, Issue 1, 1 September 2023, Pages A12-A14
Some Like It Hot: The Value of Dose and Hot Spots in Lung Stereotactic Body Radiation Therapy
Dawn Owen, MD, PhD,* Shankar Siva, PhD, MB, FRANZCR,y Joseph K. Salama, MD,z Megan Daly, MD,x Timothy J. Kruser, MD,? and Meredith Giuliani, MBBS, MEd, PhD, FRCPC
doi : 10.1016/j.ijrobp.2023.03.056
Volume 117, Issue 1, 1 September 2023, Pages 1-5
Early Glottic Cancer With Adverse Features: Can Larynx-Only RT Cut It Without Needing to Eventually Cut It Out?
Alexandra N. De Leo, MD,* and Roi Dagan, MD, MS*
doi : 10.1016/j.ijrobp.2022.06.059
Volume 117, Issue 1, 1 September 2023, Pages 6-7
Old School
Bhisham Chera, M.D.
doi : 10.1016/j.ijrobp.2023.07.012
Volume 117, Issue 1, 1 September 2023, Page 8
2B Or Not 2B?
Shlomo A. Koyfman, MD
doi : 10.1016/j.ijrobp.2023.07.013
Volume 117, Issue 1, 1 September 2023, Pages 8-9
Splitting the Difference With Intensified Radiation Therapy Alone for Borderline Early Stage Glottic Cancer
Yvonne M. Mowery, MD, PhD
doi : 10.1016/j.ijrobp.2022.08.004
Volume 117, Issue 1, 1 September 2023, Page 9
Platinum-Level Care
Trisha Wise-Draper, MD, PhD
doi : 10.1016/j.ijrobp.2022.08.003
Volume 117, Issue 1, 1 September 2023, Pages 9-10
An Environmental Scan of Advanced Practice Radiation Therapy in the United States: A PESTEL Analysis
Danielle McDonagh, MS, RT(T),* Kristi Linnea Tonning, PhD, RT(T),y Brian Freeman, MHA, RT(T),z Eva J. Birring, MBA, RT(T),x Maria Dimopoulos, PhD, MBA, RT(T),* Nicole Harnett, MRT(T), BSc,?,{ Samantha Skubish, MS, RT(R)(T),* Clodagh Starrs, APRT, PgC, RTT, # Sharon Wong Mei Mei, PhD, MSc, CMD, BSc,yy Neha Vapiwala, MD, FACR, FASTRO,zz and Kristie Matthews, PhD, MTrainDev, BAppSci (MedRad)
doi : 10.1016/j.ijrobp.2023.05.007
Volume 117, Issue 1, 1 September 2023, Pages 11-21
Evaluating Carbon Footprint of Proton Therapy Based on Power Consumption and Possible Mitigation Strategies
Tomas Dvorak, MD,* Sanford Meeks, PhD,y Lucas Dvorak,* Justin Rineer, MD,* Patrick Kelly, MD, PhD,* Naren Ramakrishna, MD, PhD,* Thomas Henig, CHFM,z Murat Kucukvar, PhD,x Nuri C. Onat, PhD,x Omer Tatari, PhD,? Amish Shah, PhD,* Jessica Salazar, PhD,* and Omar Zeidan, PhD*
doi : 10.1016/j.ijrobp.2023.05.022
Volume 117, Issue 1, 1 September 2023, Pages 22-30
Late Toxicity and Health-Related Quality of Life Following Definitive Chemoradiotherapy for Esophageal Cancer: A Systematic Review and Meta-analysis
Marieke Pape, MSc,*,y,z Linde M. Veen, MD,y,z Thom M. Smit, BSc,y,z Steven C. Kuijper, MSc,*,y Pauline A.J. Vissers, PhD,*,x Elisabeth D. Geijsen, MD,? Peter S.N. van Rossum, MD, PhD,? Mirjam A.G. Sprangers, PhD,z,{ Sarah Derks, MD, PhD,#, **,yy Rob H.A. Verhoeven, PhD,*,y,z and Hanneke W.M. van Laarhoven, MD, PhD*,
doi : 10.1016/j.ijrobp.2023.05.025
Volume 117, Issue 1, 1 September 2023, Pages 31-44
Transarterial Chemoembolization With Drug-Eluting Beads Versus Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Outcomes From a Multicenter, Randomized, Phase 2 Trial (the TRENDY Trial)
Alejandra M endez Romero, MD, PhD,* Bronno van der Holt, PhD,* Francois E.J.A. Willemssen, MD,y Rob A. de Man, MD, PhD,z Ben J.M. Heijmen, PhD,* Steven Habraken, PhD,* Henrike Westerveld, MD, PhD,x Otto M. van Delden, MD, PhD,? Heinz-Josef Kl€umpen, MD, PhD,{ Eric T.T.L. Tjwa, MD, PhD, # P etra M. Braam, MD, PhD,** Sjoerd F.M. Jenniskens, MD, PhD,yy Thomas Vanwolleghem, MD, PhD,zz Reinhilde Weytjens, MD,xx,?? Olivier d’Archambeau, MD, PhD,{{ Judith de Vos-Geelen, MD, PhD,## Jeroen Buijsen, MD, PhD,*** Christiaan van der Leij, MD, PhD,yyy Wilhelm den Toom,* Dave Sprengers, MD, PhD,z Jan N.M. IJzermans, MD, PhD,zzz and Adriaan Moelker, MD, PhD
doi : 10.1016/j.ijrobp.2023.03.064
Volume 117, Issue 1, 1 September 2023, Pages 45-52
Phase 1 Dose Escalation Study of SBRT Using 3 Fractions for Locally Advanced Pancreatic Cancer
Marsha Reyngold, MD, PhD,* Sana D. Karam, MD, PhD,y Carla Hajj, MD,* Abraham J. Wu, MD,* John Cuaron, MD,* Stephanie Lobaugh, MS,z Ellen D. Yorke, PhD,x Shannan Dickinson, MD,? Bernard Jones, PhD,y Yevgeniy Vinogradskiy, PhD,{ Amita Shukla-Dave, PhD,x,? Richard Kinh Gian Do, MD, PhD,? Carlie Sigel, MD, # Zhigang Zhang, PhD,z Christopher H. Crane, MD,* and Karyn A. Goodman, MD**
doi : 10.1016/j.ijrobp.2023.03.036
Volume 117, Issue 1, 1 September 2023, Pages 53-63
Pegylated Liposomal Mitomycin C Lipidic Prodrug in Combination With External Beam Radiation Therapy in Patients With Advanced Cancer: A Phase 1B Study
Eli Sapir, MD,* Raphael Pfeffer, MD,y Marc Wygoda, MD,z Ofer Purim, MD,* Adi Levy, MD,z Benjamin Corn, MD,x Yasmine Amitay, PhD,k Patricia Ohana, PhD,k and Alberto Gabizon, MD, PhD
doi : 10.1016/j.ijrobp.2023.03.046
Volume 117, Issue 1, 1 September 2023, Pages 64-73
Carbohydrate Antigen 19-9 Response to Initial Adjuvant Chemotherapy Predicts Survival and Failure Pattern of Resected Pancreatic Adenocarcinoma but Not Which Patients Are Suited for Additional Adjuvant Chemoradiation Therapy: From a Prospective Randomized Study
Yen-Feng Chiu,* Tsang-Wu Liu,y Yan-Shen Shan,z Jen-Shi Chen,x Chung-Pin Li,k,{,# Ching-Liang Ho,** Ruey-Kuen Hsieh,yy Tsann-Long Hwang,zz Li-Tzong Chen,y,xx,kk and Hui-Ju Ch’ang, MDy,{{,## on behalf of the Taiwan Cooperative Oncology Group pancreatic cancer study group
doi : 10.1016/j.ijrobp.2023.02.061
Volume 117, Issue 1, 1 September 2023, Pages 74-86
Low-Dose Whole Brain Radiation Therapy for Alzheimer's Dementia: Results From a Pilot Trial in Humans
C. Leland Rogers, MD,* Sarah K. Lageman, PhD,y James Fontanesi, MD,z George D. Wilson, PhD,z Peter A. Boling, MD,y Surbhi Bansal, MD,y John P. Karis, MD,x Marwan Sabbagh, MD,x Minesh P. Mehta, MD,? and Timothy J. Harris, MD, PhD
doi : 10.1016/j.ijrobp.2023.03.044
Volume 117, Issue 1, 1 September 2023, Pages 87-95
Feasibility of the Audio-Visual Assisted Therapeutic Ambience in Radiotherapy (AVATAR) System for Anesthesia Avoidance in Pediatric Patients: A Multicenter Trial
Paulina M. Gutkin, BS,*,y Lawrie Skinner, PhD,* Alice Jiang, BA,* Sarah S. Donaldson, MD,* Billy W. Loo Jr, MD, PhD,* Justin Oh, MD,* Yi Peng Wang, BA,* Rie von Eyben, MS,* John Snyder, MS,* Jeremy S. Bredfeldt, PhD,z John C. Breneman, MD,x Louis S. Constine, MD,? Austin M. Faught, PhD,{ Daphne Haas-Kogan, MD,z Jordan A. Holmes, MD, # Matthew Krasin, MD,{ Charlene Larkin, CCLS,x Karen J. Marcus, MD,z Peter G. Maxim, PhD,** Shearwood McClelland III, MD,yy Blair Murphy, MD,zz Joshua D. Palmer, MD,xx Stephanie M. Perkins, MD,?? Colette J. Shen, MD,{{ Stephanie Terezakis, MD, ## Karl Bush, PhD,* and Susan M. Hiniker, MD
doi : 10.1016/j.ijrobp.2023.03.063
Volume 117, Issue 1, 1 September 2023, Pages 96-104
Neoadjuvant Osimertinib Followed by Sequential Definitive Radiation Therapy and/or Surgery in Stage III Epidermal Growth Factor Receptor–Mutant Non-Small Cell Lung Cancer: An Open-Label, Single-Arm, Phase 2 Study
Nir Peled, MD, PhD, FCCP,*, **,2 Laila C. Roisman, PhD, *, **, 2 Esther Levison, MD,y Julia Dudnik, MD,y Elena Chernomordikov, MD,y Norman Heching, MD,*, ** Elizabeth Dudnik, MD,z Shoshana Keren-Rosenberg, MD,x Hovav Nechushtan, MD,? Ayman Salhab, MD,? Dov Hershkovitz, MD,{ Shlomo Tsuriel, PhD,{ Victoria Hannes,{ Ofer Rotem, MD,z Irina Lazarev, MD, # Rachel Lichtenberg, MD,y Inbal S. Granot, RN,*, ** Bilal Krayim, MD,*, ** Walid Shalata, MD,y Daniel Levin, MD,y Yanay Krutman, PhD,y Aaron M. Allen, MD,*, ** Philip Blumenfeld, MD,{ Konstantin Lavrenkov, MD,y and Waleed Kian, MD
doi : 10.1016/j.ijrobp.2023.03.042
Volume 117, Issue 1, 1 September 2023, Pages 105-114
Radiation Therapy in the Molecular Era of Lung Cancer: How Best to Integrate Targeted Therapeutics With Definitive Radiation Therapy for Epidermal Growth Factor Receptor–Mutant Unresectable Stage III Non-Small Cell Lung Cancer?
Benjamin H. Lok, MD
doi : 10.1016/j.ijrobp.2023.03.074
Volume 117, Issue 1, 1 September 2023, Pages 115-117
Safety and Efficacy Results From iSABR, a Phase 1 Study of Stereotactic ABlative Radiotherapy in Combination With Durvalumab for Early-Stage Medically Inoperable Non-Small Cell Lung Cancer
Trudy C. Wu, MD,* Annalise Stube, BS,* Carol Felix, BS,* Denise Oseguera, BS,y Tahmineh Romero, PhD,z Jonathan Goldman, MD,y Edward B. Garon, MD,y Jay M. Lee, MD,x John Glaspy, MD,y Aaron E. Lisberg, MD,y Chad G. Rusthoven, MD,? D. Ross Camidge, MD, PhD,{ Shankar Siva, MBBS, PhD, # Benjamin Solomon, MBBS, PhD,** Alan Lee, MD,* Stephen E. Tenn, PhD,* Narek Shaverdian, MD,yy Michael L. Steinberg, MD,* Ann C. Raldow, MD, MPH,* and Percy Lee, MD
doi : 10.1016/j.ijrobp.2023.03.069
Volume 117, Issue 1, 1 September 2023, Pages 118-122
Neoadjuvant Simultaneous Integrated Boost Radiation Therapy Improves Clinical Outcomes for Retroperitoneal Sarcoma
Casey L. Liveringhouse, MD,* Russell F. Palm, MD,* John M. Bryant, MD,* George Q. Yang, MD,* Matthew N. Mills, MD,* Nicholas D. Figura, MD,* Kamran A. Ahmed, MD,* John Mullinax, MD,y Ricardo Gonzalez, MD,y Peter A. Johnstone, MD,* and Arash O. Naghavi, MD, MS
doi : 10.1016/j.ijrobp.2023.03.037
Volume 117, Issue 1, 1 September 2023, Pages 123-138
A Prospective Study of Chemoradiotherapy as Primary Treatment in Patients With Locoregionally Advanced Penile Carcinoma
Sarah Rosanne Ottenhof, MD, PhD,* Hielke Martijn de Vries, MD,* Barry Doodeman,y Gerbert Lambertus Vrijenhoek,y Vincent van der Noort, PhD,z Maarten Lucas Donswijk, MD,x Jeantine Martina de Feijter, MD, PhD,? Eva Eline Schaake, MD, PhD,y Simon Horenblas, MD, PhD,* Oscar Roberto Brouwer, MD, PhD,* Michiel Simon van der Heijden, MD, PhD,? and Floris Jop Pos, MD, PhD
doi : 10.1016/j.ijrobp.2023.03.066
Volume 117, Issue 1, 1 September 2023, Pages 139-147
Is Substantial Lymphovascular Space Invasion Prognostic in Patients With Pathologically Lymph Node-Negative Endometrial Cancer?
Phillip M. Pifer, MD, PhD,* Sruthi Jaishankar, BS,* Rohit Bhargava, MD,y Michael D. Schad, BS,* Andrew Keller, MD,* Hima Bindu Musunuru, MD,* Michael Cohen, MD,z Paniti Sukumvanich, MD,z Madeleine Courtney-Brooks, MD, MPH,z Michelle Boisen, MD,z Jessica L. Berger, MD,z Alexander Olawaiye, MD,z Jamie Lesnock, MD,z Robert Edwards, MD,z Sarah Taylor, MD, PhD,z John Austin Vargo, MD,* and Sushil Beriwal, MD, MBA
doi : 10.1016/j.ijrobp.2023.02.053
Volume 117, Issue 1, 1 September 2023, Pages 148-153
The Updated World Health Organization Classification Better Predicts Survival in Patients With Endocervical Adenocarcinoma (KROG 20-07)
Won Kyung Cho, MD,* Hyun-Soo Kim, MD,y Won Park, MD,* Yeon-Sil Kim, MD,z Jun Kang, MD,x Yong Bae Kim, MD,? Young Seok Kim, MD,{ Yeon Joo Kim, MD,{ Kyu-Rae Kim, MD, # Jin Hee Kim, MD,** Sun Young Kwon, MD,yy Jin Hwa Choi, MD,zz Meesun Yoon, MD,xx and Nah Ihm Kim, MD
doi : 10.1016/j.ijrobp.2023.03.048
Volume 117, Issue 1, 1 September 2023, Pages 154-163
Ultrahypofractionated Low-Dose Total Skin Electron Beam in Advanced-Stage Mycosis Fungoides and Sézary Syndrome
Khaled Elsayad, PhD,* Carsten Weishaupt, PhD,y Christos Moustakis, PhD,* Moritz Fabian Danzer, MSc,z Elisa Christina M€uller, MD,* Daniel Rolf, MD,* Rene Stranzenbach, PhD,x Elisabeth Livingstone, PhD,? Nina Booken, PhD,{ Rudolf Stadler, PhD,# and Hans Theodor Eich, PhD*
doi : 10.1016/j.ijrobp.2023.02.052
Volume 117, Issue 1, 1 September 2023, Pages 164-170
Initial Feasibility and Acute Toxicity Outcomes From a Phase 2 Trial of 18F-Fluorodeoxyglucose Positron Emission Tomography Response-Based De-escalated Definitive Chemoradiotherapy for p16+ Oropharynx Cancer: A Planned Interim Analysis
Steven G. Allen, MD, PhD,*,a Benjamin S. Rosen, PhD,* ,a Madhava Aryal, PhD,* Yue Cao, PhD,* Matthew J. Schipper, PhD,y Ka Kit Wong, MBBS,z Keith A. Casper, MD,x Steven B. Chinn, MD, MPH,x Kelly M. Malloy, MD,x Mark E. Prince, MD,x Andrew J. Rosko, MD,x Andrew G. Shuman, MD,x,? Matthew E. Spector, MD,x Chaz L. Stucken, MD,x Paul L. Swiecicki, MD,{ Francis P. Worden, MD,{ J. Chad Brenner, PhD,x Caitlin A. Schonewolf, MD,* David A. Elliott, MD,# Michelle L. Mierzwa, MD,* and Jennifer L. Shah, MD
doi : 10.1016/j.ijrobp.2023.03.043
Volume 117, Issue 1, 1 September 2023, Pages 171-180
In-Field Toxicity Analysis of a Phase 1 Clinical Trial of Nivolumab and Ipilimumab With Definitive Radiation Therapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Ayesha S. Ali, MD,* Gregor Manukian, MD, PhD,* Jennifer M. Johnson, MD, PhD,y,z Ioannis Vathiotis, MD,y Rita Axelrod, MD,y Scott W. Keith, PhD,x Joseph Curry, MD,z David Cognetti, MD,z Adam Luginbuhl, MD,z Athanassios Argiris, MD, PhD,y and Voichita Bar-Ad, MD
doi : 10.1016/j.ijrobp.2023.03.065
Volume 117, Issue 1, 1 September 2023, Pages 181-185
Dose-Volume Predictors for Radiation Esophagitis in Patients With Breast Cancer Undergoing Hypofractionated Regional Nodal Radiation Therapy
Dan-Qiong Wang, MD,* Na Zhang, MD,y Li-Hua Dong, MD,z Ya-Hua Zhong, MD,x Hong-Fen Wu, MD,? Qiu-Zi Zhong, MD,{ Jing Jin, MD, # Xiao-Rong Hou, MD,** Hao Jing, MD,* Yu Tang, MD,* Chen Hu, MD,yy Yong-Wen Song, MD,* Yue-Ping Liu, MD,* Shu-Nan Qi, MD,* Yuan Tang, MD,* Ning-Ning Lu, MD,* Bo Chen, MD,* Yi-Rui Zhai, MD,* Wen-Wen Zhang, MD,* Ning Li, MD,* Hui Fang, MD,* Ye-Xiong Li, MD,* and Shu-Lian Wang, MD*
doi : 10.1016/j.ijrobp.2023.03.060
Volume 117, Issue 1, 1 September 2023, Pages 186-197
DSTN Hypomethylation Promotes Radiotherapy Resistance of Rectal Cancer by Activating the Wnt/β-Catenin Signaling Pathway
Rongbo Wen, MD,* Leqi Zhou, PhD,* Siyuan Jiang, MD,* Hao Fan, MD,* Kuo Zheng, MD,* Yue Yu, PhD,* Xianhua Gao, MD,* Liqiang Hao, MD,* Zheng Lou, MD,* Guanyu Yu, MD,* Fu Yang, PhD,y and Wei Zhang, MD
doi : 10.1016/j.ijrobp.2023.03.067
Volume 117, Issue 1, 1 September 2023, Pages 198-210
The Role of Destrin Wnt/β-Catenin Signaling Pathway in Rectal Cancer Oncogenesis
Vincent Ho, FRACP, PhD,* and Cameron M. Callaghan, MD, MPH, MS
doi : 10.1016/j.ijrobp.2023.05.003
Volume 117, Issue 1, 1 September 2023, Pages 211-213
Radiation-Chemical Oxygen Depletion Depends on Chemical Environment and Dose Rate: Implications for the FLASH Effect
Cameron J. Koch, PhD, Michele M. Kim, PhD, and Rodney D. Wiersma, PhD
doi : 10.1016/j.ijrobp.2023.04.001
Volume 117, Issue 1, 1 September 2023, Pages 214-222
High-Dose Ionizing Radiation Accelerates Atherosclerotic Plaque Progression by Regulating P38/NCOA4-Mediated Ferritinophagy/Ferroptosis of Endothelial Cells
Zhinan Wu, MD, Taiwei Chen, MD, Yuxuan Qian, MD, Guqing Luo, MD, Fei Liao, MD, Xinjie He, MD, Wenyi Xu, MD, Jun Pu, MD, PhD, and Song Ding, MD, PhDT a g g e d A P T A R A E n d
doi : 10.1016/j.ijrobp.2023.04.004
Volume 117, Issue 1, 1 September 2023, Pages 223-236
A Subset of Breg Cells, B10, Contributes to the Development of Radiation-Induced Pulmonary Fibrosis
Xiaoxian Pan, MS,*,y Caihong Wang, MS,*,y Yuping Zhan, MS,*,y Jinmei Chen, MS,*,y,z Zeng Wang, PhD,z,{ Ruilong Lan, MS,x,{ Junying Chen, MS,z,{ Weijian Zhang, MS,*,y,z Chun Chen, PhD,k Mingwei Zhang, PhD,*,y,z Fei Huang, PhD,x,{ and Jinsheng Hong, PhD*,y
doi : 10.1016/j.ijrobp.2023.03.077
Volume 117, Issue 1, 1 September 2023, Pages 237-251
Evaluation of the Yield of DNA Double-Strand Breaks for Carbon Ions Using Monte Carlo Simulation and DNA Fragment Distribution
Ying Liang, PhD,* Jianan Wu, PhD,* Zhen Ding, PhD,* Chenbin Liu, PhD,* and Qibin Fu, PhD
doi : 10.1016/j.ijrobp.2023.03.049
Volume 117, Issue 1, 1 September 2023, Pages 252-261
An End-to-End Natural Language Processing System for Automatically Extracting Radiation Therapy Events From Clinical Texts
Danielle S. Bitterman, MD,* ,y,z,2 Eli Goldner, MS,* ,2 Sean Finan, BS,* David Harris, BA,* Eric B. Durbin, PhD,x,? Harry Hochheiser, PhD,{ Jeremy L. Warner, MD, #, ** Raymond H. Mak, MD,y,z Timothy Miller, PhD,* and Guergana K. Savova, PhD
doi : 10.1016/j.ijrobp.2023.03.055
Volume 117, Issue 1, 1 September 2023, Pages 262-273
Dosimetric Evaluation of Organs at Risk From SAVE Protocol
Jeremy N. Kunz, PhD,* Y. Jessica Huang, PhD,* Anthony C. Casper, DO,* Gita Suneja, MD,* Lindsay M. Burt, MD,* Anuja Jhingran, MD,y Melissa M. Joyner, MD,y Matthew M. Harkenrider, MD,z William Small, JrMD,z Jonathan D. Grant, MD,x Elizabeth A. Kidd, MD,? Ken Boucher, PhD,{ and David K. Gaffney, MD, PhD
doi : 10.1016/j.ijrobp.2023.03.071
Volume 117, Issue 1, 1 September 2023, Pages 274-280
In Regard to Shah et al.
Jason M. Beckta, MD, PhD
doi : 10.1016/j.ijrobp.2023.04.016
Volume 117, Issue 1, 1 September 2023, Pages 281-282
In Regard to Shah et al.
Khush Singh Aujla, MD
doi : 10.1016/j.ijrobp.2023.04.017
Volume 117, Issue 1, 1 September 2023, Page 282
In Reply to Dr. Beckta and Dr. Aujla
Greg Vachon, MD, MPHChirag Shah, MDPranshu Mohindra, MDAnna Arnone,Bruce Haffty, MD
doi : 10.1016/j.ijrobp.2023.04.019
Volume 117, Issue 1, 1 September 2023, Pages 282-284
In Regard to Liveringhouse et al.
Alper Kahvecioglu, MD Sezin Yuce Sari, MD Gozde Yazici, MD
doi : 10.1016/j.ijrobp.2023.05.010
Volume 117, Issue 1, 1 September 2023, Pages 284-285
In Reply to Kahvecioglu et al.
Casey L. Liveringhouse, MD George Q. Yang, MD Arash O. Naghavi, MD, MS
doi : 10.1016/j.ijrobp.2023.05.009
Volume 117, Issue 1, 1 September 2023, Pages 285-286
In Regard to Park et al.
Irfan Ahmad, DNB Kundan Singh Chufal, MD
doi : 10.1016/j.ijrobp.2023.05.020
Volume 117, Issue 1, 1 September 2023, Pages 286-287
In Reply to Ahmad et al.
Ye-In Park, MSKyubo Kim, MD, PhD
doi : 10.1016/j.ijrobp.2023.05.024
Volume 117, Issue 1, 1 September 2023, Pages 287-288
In Regard to McDonagh et al.
Marsha Haley, MD, MPH
doi : 10.1016/j.ijrobp.2023.06.017
Volume 117, Issue 1, 1 September 2023, Pages 288-289
In Reply to Haley
Danielle McDonagh, MS, RT(T)Maria Dimopoulos, PhD, MBA, RT(T)Kristi Linnea Tonning, PhD, RT(T)Brian Freeman, MHA, RT(T)Eva J. Birring, MBA, RT(T)Nicole Harnett, MRT(T), BSc, MedSamantha Skubish, MS, RT(R)(T)Clodagh Starrs, APRT, PgC, RTTSharon Wong Mei Mei, PhD, MSc, CMD, BScNeha Vapiwala, MD, FACR, FASTROKristie Matthews, PhD, MTrainDev, BAppSci(MedRad)
doi : 10.1016/j.ijrobp.2023.06.021
Volume 117, Issue 1, 1 September 2023, Pages 289-290
